These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32859328)

  • 1. The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study.
    Thomsen MN; Skytte MJ; Astrup A; Deacon CF; Holst JJ; Madsbad S; Krarup T; Haugaard SB; Samkani A
    Clin Nutr ESPEN; 2020 Oct; 39():46-52. PubMed ID: 32859328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A carbohydrate-reduced high-protein diet improves HbA
    Skytte MJ; Samkani A; Petersen AD; Thomsen MN; Astrup A; Chabanova E; Frystyk J; Holst JJ; Thomsen HS; Madsbad S; Larsen TM; Haugaard SB; Krarup T
    Diabetologia; 2019 Nov; 62(11):2066-2078. PubMed ID: 31338545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
    Thomsen MN; Skytte MJ; Samkani A; Carl MH; Weber P; Astrup A; Chabanova E; Fenger M; Frystyk J; Hartmann B; Holst JJ; Larsen TM; Madsbad S; Magkos F; Thomsen HS; Haugaard SB; Krarup T
    Diabetologia; 2022 Mar; 65(3):506-517. PubMed ID: 34993571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients.
    Samkani A; Skytte MJ; Kandel D; Kjaer S; Astrup A; Deacon CF; Holst JJ; Madsbad S; Rehfeld JF; Haugaard SB; Krarup T
    Br J Nutr; 2018 Apr; 119(8):910-917. PubMed ID: 29644957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial.
    Williams DM; Parsons SN; Dunseath GJ; Stephens JW; Luzio SD; Owens DR
    Diabetes Metab Syndr; 2020; 14(2):101-106. PubMed ID: 31995784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial.
    Tay J; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Noakes M; Buckley JD; Wittert GA; Yancy WS; Brinkworth GD
    Diabetes Obes Metab; 2018 Apr; 20(4):858-871. PubMed ID: 29178536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carbohydrate restriction on postprandial glucose metabolism,
    Skytte MJ; Samkani A; Astrup A; Frystyk J; Rehfeld JF; Holst JJ; Madsbad S; Burling K; Fenger M; Thomsen MN; Larsen TM; Krarup T; Haugaard SB
    Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E7-E18. PubMed ID: 33103448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Real-Time Continuous Glucose Monitoring to Improve Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A Pilot Study.
    Taylor PJ; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Wittert G; Brinkworth GD
    Diabetes Ther; 2019 Apr; 10(2):509-522. PubMed ID: 30706365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of basic carbohydrate counting versus standard dietary care for glycaemic control in type 2 diabetes (The BCC Study): a randomised, controlled trial.
    Ewers B; Blond MB; Bruun JM; Vilsbøll T
    Nutr Diabetes; 2024 Jun; 14(1):47. PubMed ID: 38937460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial.
    Karstoft K; Clark MA; Jakobsen I; Müller IA; Pedersen BK; Solomon TP; Ried-Larsen M
    Diabetologia; 2017 Mar; 60(3):508-517. PubMed ID: 27942800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study).
    Kwak SH; Hwang YC; Won JC; Bae JC; Kim HJ; Suh S; Lee EY; Lee S; Kim SY; Kim JH
    Diabetes Obes Metab; 2020 Feb; 22(2):173-181. PubMed ID: 31502749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reducing free sugars on 24-hour glucose profiles and glycemic variability in subjects without diabetes.
    Pappe CL; Peters B; Dommisch H; Woelber JP; Pivovarova-Ramich O
    Front Nutr; 2023; 10():1213661. PubMed ID: 37850088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial.
    Samkani A; Skytte MJ; Anholm C; Astrup A; Deacon CF; Holst JJ; Madsbad S; Boston R; Krarup T; Haugaard SB
    Lipids Health Dis; 2018 Dec; 17(1):295. PubMed ID: 30591062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.
    Frías JP; Nakhle S; Ruggles JA; Zhuplatov S; Klein E; Zhou R; Strange P
    Diabetes Obes Metab; 2017 Jan; 19(1):40-48. PubMed ID: 27527911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised crossover trial: Exploring the dose-response effect of carbohydrate restriction on glycaemia in people with well-controlled type 2 diabetes.
    Al-Ozairi E; Reem AA; El Samad A; Taghadom E; Al-Kandari J; Abdul-Ghani M; Oliver N; Whitcher B; Guess N
    J Hum Nutr Diet; 2023 Feb; 36(1):51-61. PubMed ID: 35560850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.
    Thomsen MN; Skytte MJ; Samkani A; Astrup A; Fenger M; Frystyk J; Hartmann B; Holst JJ; Larsen TM; Madsbad S; Magkos F; Rehfeld JF; Haugaard SB; Krarup T
    Front Nutr; 2022; 9():933118. PubMed ID: 36061897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational assessments of the relationship of dietary and pharmacological treatment on continuous measures of dysglycemia over 24 hours in women with gestational diabetes.
    Dingena CF; Holmes MJ; Campbell MD; Cade JE; Scott EM; Zulyniak MA
    Front Endocrinol (Lausanne); 2023; 14():1065985. PubMed ID: 36777347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial.
    Vianna AGD; Lacerda CS; Pechmann LM; Polesel MG; Marino EC; Scharf M; Detsch JM; Marques K; Sanches CP
    Diabetes Obes Metab; 2020 Apr; 22(4):501-511. PubMed ID: 31709738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial.
    Jensen NJ; Wodschow HZ; Skytte MJ; Samkani A; Astrup A; Frystyk J; Hartmann B; Holst JJ; Larsen TM; Madsbad S; Magkos F; Miskowiak KW; Haugaard SB; Krarup T; Rungby J; Thomsen MN
    Clin Nutr; 2022 Jul; 41(7):1605-1612. PubMed ID: 35679680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a low-carbohydrate high-fat diet and ethnicity on daily glucose profile in type 2 diabetes determined by continuous glucose monitoring.
    Blaychfeld-Magnazi M; Reshef N; Zornitzki T; Madar Z; Knobler H
    Eur J Nutr; 2020 Aug; 59(5):1929-1936. PubMed ID: 31292751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.